Q4 2025 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2026-02-17 · accession 0001214659-26-001960
$318.6M
Reported value
15
Positions
2025-12-31
Period end
The Brief · BOONE CAPITAL MANAGEMENT LLC · Q4 2025
AI · grounded in 13F
BOONE CAPITAL MANAGEMENT LLC established a new position in ASTRAZENECA PLC valued at $20.2M. The fund also opened new stakes in HQY for $19.5M and TYRA for $10.5M. These additions coincided with the closure of positions in ICON PLC, COGT, and UNIQURE NV.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G5960L103 | MDT | MEDTRONIC PLC | $41.2M | 12.9% | 428,789 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $33.3M | 10.4% | 421,236 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $33.1M | 10.4% | 417,833 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $26.5M | 8.33% | 96,453 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $24.5M | 7.68% | 411,880 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $21.5M | 6.76% | 151,815 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $20.4M | 6.40% | 61,762 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $20.2M | 6.35% | 220,201 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $19.5M | 6.12% | 212,856 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $17.8M | 5.58% | 288,895 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $15.9M | 5.00% | 470,456 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $14.1M | 4.44% | 184,963 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $14.1M | 4.42% | 503,830 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $10.5M | 3.29% | 398,482 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $6.0M | 1.88% | 352,144 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.